4DMedical Limited (ASX:4DX)
Australia flag Australia · Delayed Price · Currency is AUD
1.810
+0.060 (3.43%)
Sep 26, 2025, 4:10 PM AEST
3.43%
Market Cap905.04M
Revenue (ttm)5.85M
Net Income (ttm)-30.07M
Shares Out500.02M
EPS (ttm)-0.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,453,236
Average Volume16,133,325
Open1.755
Previous Close1.750
Day's Range1.715 - 1.855
52-Week Range0.225 - 2.380
Beta1.71
RSI63.09
Earnings DateNov 27, 2025

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functiona... [Read more]

Sector Healthcare
Founded 2012
Employees 145
Stock Exchange Australian Securities Exchange
Ticker Symbol 4DX
Full Company Profile

Financial Performance

In 2025, 4DMedical's revenue was 5.85 million, an increase of 55.91% compared to the previous year's 3.75 million. Losses were -30.07 million, -16.42% less than in 2024.

Financial Statements

News

There is no news available yet.